Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease

被引:273
作者
Aho, Velma T. E. [1 ,2 ,3 ]
Houser, Madelyn C. [4 ,5 ]
Pereira, Pedro A. B. [1 ,2 ,3 ]
Chang, Jianjun [5 ]
Rudi, Knut [6 ]
Paulin, Lars [1 ]
Hertzberg, Vicki [4 ]
Auvinen, Petri [1 ]
Tansey, Malu G. [5 ,7 ]
Scheperjans, Filip [2 ,3 ]
机构
[1] Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Viikinkaari 5D, Helsinki 00790, Finland
[2] Helsinki Univ Hosp, Dept Neurol, Ward K4A,Haartmaninkatu 4, FI-00290 Helsinki, Finland
[3] Univ Helsinki, Dept Neurol Sci Neurol, Ward K4A,Haartmaninkatu 4, FI-00290 Helsinki, Finland
[4] Emory Univ, Nell Hodgson Woodruff Sch Nursing, 1520 Clifton Rd, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Dept Physiol, 615 Michael St, Atlanta, GA 30322 USA
[6] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci KBM, N-1433 As, Norway
[7] Univ Florida, Dept Neurosci & Neurol, Ctr Translat Res Neurodegenerat Dis, Coll Med, 1149 Newell Dr, Gainesville, FL 32611 USA
基金
芬兰科学院;
关键词
Parkinson’ s disease; Microbiota; Intestine; Inflammation; Short-chain fatty acids; INTESTINAL INFLAMMATION; ALZHEIMERS-DISEASE; BRAIN AXIS; BIOMARKERS; ABERRATIONS;
D O I
10.1186/s13024-021-00427-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background Previous studies have reported that gut microbiota, permeability, short-chain fatty acids (SCFAs), and inflammation are altered in Parkinson's disease (PD), but how these factors are linked and how they contribute to disease processes and symptoms remains uncertain. This study sought to compare and identify associations among these factors in PD patients and controls to elucidate their interrelations and links to clinical manifestations of PD. Methods Stool and plasma samples and clinical data were collected from 55 PD patients and 56 controls. Levels of stool SCFAs and stool and plasma inflammatory and permeability markers were compared between patients and controls and related to one another and to the gut microbiota. Results Calprotectin was increased and SCFAs decreased in stool in PD in a sex-dependent manner. Inflammatory markers in plasma and stool were neither intercorrelated nor strongly associated with SCFA levels. Age at PD onset was positively correlated with SCFAs and negatively correlated with CXCL8 and IL-1 beta in stool. Fecal zonulin correlated positively with fecal NGAL and negatively with PD motor and non-motor symptoms. Microbiota diversity and composition were linked to levels of SCFAs, inflammatory factors, and zonulin in stool. Certain relationships differed between patients and controls and by sex. Conclusions Intestinal inflammatory responses and reductions in fecal SCFAs occur in PD, are related to the microbiota and to disease onset, and are not reflected in plasma inflammatory profiles. Some of these relationships are distinct in PD and are sex-dependent. This study revealed potential alterations in microbiota-host interactions and links between earlier PD onset and intestinal inflammatory responses and reduced SCFA levels, highlighting candidate molecules and pathways which may contribute to PD pathogenesis and clinical presentation and which warrant further investigation.
引用
收藏
页数:14
相关论文
共 53 条
[1]   Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression [J].
Aho, Velma T. E. ;
Pereira, Pedro A. B. ;
Voutilainen, Sari ;
Paulin, Lars ;
Pekkonen, Eero ;
Auvinen, Petri ;
Scheperjans, Filip .
EBIOMEDICINE, 2019, 44 :691-707
[2]   Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients [J].
Bedarf, J. R. ;
Hildebrand, F. ;
Coelho, L. P. ;
Sunagawa, S. ;
Bahram, M. ;
Goeser, F. ;
Bork, P. ;
Wuellner, U. .
GENOME MEDICINE, 2017, 9
[3]  
Bjarnason Ingvar, 2017, Gastroenterol Hepatol (N Y), V13, P53
[4]   Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review [J].
Boertien, Jeffrey M. ;
Pereira, Pedro A. B. ;
Aho, Velma T. E. ;
Scheperjans, Filip .
JOURNAL OF PARKINSONS DISEASE, 2019, 9 :S297-S312
[5]  
Bork P, 2016, ENTEROTYPES REFERENC
[6]   The endotoxin hypothesis of neurodegeneration [J].
Brown, Guy C. .
JOURNAL OF NEUROINFLAMMATION, 2019, 16 (01) :180
[7]   Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis [J].
Bullich, Clara ;
Keshavarzian, Ali ;
Garssen, Johan ;
Kraneveld, Aletta ;
Perez-Pardo, Paula .
MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (08) :639-651
[8]   Peripheral inflammatory biomarkers and risk of Parkinson's disease [J].
Chen, Honglei ;
O'Reilly, Eilis J. ;
Schwarzschild, Michael A. ;
Ascherio, Alberto .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (01) :90-95
[9]   Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis [J].
Chen, Xi ;
Hu, Yang ;
Cao, Zongze ;
Liu, Qingshan ;
Cheng, Yong .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[10]   Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease [J].
Cirstea, Mihai S. ;
Yu, Adam C. ;
Golz, Ella ;
Sundvick, Kristen ;
Kliger, Daniel ;
Radisavljevic, Nina ;
Foulger, Liam H. ;
Mackenzie, Melissa ;
Huan, Tau ;
Finlay, B. Brett ;
Appel-Cresswell, Silke .
MOVEMENT DISORDERS, 2020, 35 (07) :1208-1217